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The expression of virulence determinants in Staphylococcus aureus
is controlled by global regulatory loci (e.g., sarA and agr). The sar
(Staphylococcus accessory regulator) locus is composed of three
overlapping transcripts (sarA P1, P3, and P2, transcripts initiated
from the P1, P3, and P2 promoters, respectively), all encoding the
124-aa SarA protein. The level of SarA, the major regulatory
protein, is partially controlled by the differential activation of the
sarA promoters. We previously partially purified a 13.6-kDa pro-
tein, designated SarR, that binds to the sarA promoter region to
down-modulate sarA transcription from the P1 promoter and
subsequently SarA expression. SarR shares sequence similarity to
SarA, and another SarA homolog, SarS. Here we report the 2.3
Å-resolution x-ray crystal structure of the dimeric SarR-MBP (mal-
tose binding protein) fusion protein. The structure reveals that the
SarR protein not only has a classic helix–turn–helix module for DNA
binding at the major grooves, but also has an additional loop
region involved in DNA recognition at the minor grooves. This
interaction mode could represent a new functional class of the
‘‘winged helix’’ family. The dimeric SarR structure could accommo-
date an unusually long stretch of ’27 nucleotides with two or four
bending points along the course, which could lead to the bending
of DNA by 90° or more, similar to that seen in the catabolite
activator protein (CAP)–DNA complex. The structure also demon-
strates the molecular basis for the stable dimerization of the SarR
monomers and possible motifs for interaction with other proteins.
S taphylococcus aureus is a versatile bacterium capable ofcausing a wide spectrum of pathology in humans, ranging
from superficial abscesses to pneumonia, endocarditis, and
sepsis (1). This versatility may be attributable to the impressive
array of extracellular and cell-wall-associated virulence deter-
minants coordinately expressed during the process of infection
(2). The coordinate expression of many virulence determinants
in S. aureus has been shown to be regulated by global regulatory
elements such as sarA (Staphylococcus accessory regulator) and
agr (accessory global regulator) (3, 4). These regulatory ele-
ments, in turn, control the transcription of a wide variety
of unlinked genes, many of which have been implicated in
pathogenesis.
The global regulatory locus agr encodes a two-component,
quorum sensing system that is involved in the generation of two
divergent transcripts, RNAII and RNAIII, from two distinct
promoters, P2 and P3, respectively. RNAIII, initiated from the
P3 promoter, is the regulatory molecule of the agr response,
hence responsible for the up-regulation in extracellular protein
production and the down-regulation of cell-wall-associated pro-
tein synthesis during the postexponential growth phase (5, 6).
The RNAII molecule, driven by the P2 promoter, encodes a
four-gene operon, agrBDCA. Additionally, agrD, in conjunction
with agrB, participates in the generation of an octapeptide with
quorum sensing functions (7, 8). This autoinducing peptide can
stimulate the transcription of the agr regulatory molecule
RNAIII, which ultimately interacts with target genes to modu-
late transcription (6) and possibly translation (9).
In contrast to agr, the sarA locus activates the synthesis of both
extracellular (e.g., a- and b-hemolysins) and cell-wall proteins
(e.g., fibronectin binding protein A) in S. aureus (3). The sarA
locus is composed of three overlapping transcripts [sarA P1 (0.56
kb), sarA P3 (0.8 kb), and sarA P2 (1.2 kb) transcripts]. Because
of their overlapping nature, each of these transcripts encodes the
major 372-bp sarA gene, yielding the 14.5-kDa SarA protein (10).
DNA footprinting studies revealed that the SarA protein binds
to the promoters of several target genes (11) including agr, hla
(a hemolysin gene), spa (protein A gene), and fnbA (fibronectin
binding protein A gene), thus implicating SarA as a regulatory
molecule that can modulate target gene transcription via both
agr-dependent and agr-independent pathways (11–13).
The complexity of the sarA triple promoter system also hints
at the possibility that regulatory proteins may bind to the sarA
promoter region to modulate sarA transcription and, subse-
quently, SarA expression. Using a DNA-affinity column, we
recently identified a 13.6-kDa protein, designated SarR (14), that
shares homology with SarA and SarH1 (also called SarS),
another SarA homolog (15). SarR binds upstream of the sarA P1
and P3 promoter region to modulate SarA expression (16). A
mutation in sarR decreases transcription from the P1 promoter,
the predominant sarA promoter, and hence the ensuing SarA
expression. To provide a framework for understanding how SarR
behaves as a DNA-binding protein, which have dual functions of
repressor as well as activator, we solved the crystal structure of
SarR.
Materials and Methods
Protein Expression, Purification, and Crystallization. The intact
345-bp sarR gene was amplified by PCR using chromosomal
DNA from S. aureus strain RN6390 as the template and primers
containing flanking restriction sites (NdeI and BamHI) to facil-
itate cloning into an expression vector pMAL-c2 (New England
Biolabs) modified by truncating 21 residues from the linker
region that connects SarR and maltose binding protein (MBP;
R.L. and G.Z., unpublished data). The recombinant plasmid
containing the sarR gene was transformed to E. coli
BL21(DE3)pLysS. Enhanced expression of SarR-MBP fusion
was induced by adding IPTG (isopropyl 1-thio-b-D-galactopyr-
anoside) to a 4-l growing culture (37°C) at an OD650 of 0.7. After
4 h of additional growth, cells were harvested, resuspended in
buffer (50 mM TriszHCl, 1 mM EDTA, pH 7.4, 300 mM NaCl,
5% glycerol, and 1 mM DTT) and subjected to cell lysis through
Abbreviation: MPB, maltose binding protein; sar, Staphylococcus accessory regulator; agr,
accessory global regulator; CAP, catabolite activator protein.
Data deposition: The atomic coordinates have been deposited in the Protein Data Bank,
www.rcsb.org (PDB ID code 1HSJ).
‡To whom reprint requests should be addressed at: 1400 Jackson Street, 501b, Denver, CO
80206. E-mail: zhangg@njc.org.
The publication costs of this article were defrayed in part by page charge payment. This
article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C.
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a continuous-f low French press. After a 20,000 3 g spin, the
soluble fraction was loaded onto an amylose resin affinity
column (10 ml) and the SarR-MBP fusion protein was eluted
with 10 mM maltose. The protein was loaded onto a MonoQ
(Amersham Pharmacia) ion-exchange column. After elution
with a NaCl gradient (0.1 to 0.5 M), the fraction containing the
protein was found to be homogeneous as determined by a
Coomassie-stained SDS-polyacrylamide gel. The concentration
of the purified protein was determined with the Bio-Rad Protein
Assay solution, using BSA as the standard. The SarR-MBP
fusion protein (15 mg/ml) was crystallized by vapor diffusion
against a solution of 5 mM b-mercaptoethanol, 100 mM Na
acetate, 100 mM NaCl, pH 4.6, and 18–22% PEG monomethyl
ether 2000. For cryo-crystallography, crystals were soaked in
steps of increasing glycerol concentration (5% each step every 30
min) and finally into 20% glycerol before flash-freezing.
Structure Determination and Refinement. Data were collected in
the laboratory on a Rigaku R-axis IV system and beamline 5.0.2
at the Advanced Light Source (ALS) at Berkeley. Data process-
ing was performed with DENZO and SCALEPACK (17). The initial
phases were obtained by a molecular replacement solution using
the available MBP structure (18) and the program AMORE (19).
Fo-Fc and 2Fo-Fc electron density maps were calculated by CNS
(20). Map interpretation and model building were done by using
the program O (21) and aided by the secondary prediction results
(22). The map was improved by cycles of refinement using CNS
with Non-Crystallographic Symmetry (NCS) constraints. A
final refinement was performed with relaxed NCS restraints
Fig. 1. (A) A ribbon (27) diagram of the three-dimensional structure of the SarR-MBP fusion protein. The SarR dimer is at the top colored green and yellow
for each monomer, respectively, and the two MBP molecules are at the bottom colored blue and pink, respectively. (B) A worm diagram of the three-dimensional
structure of the SarR monomer. Starting from the N terminus, a1 (6–24)3a2 (32–44)3b1 (47–50)3a3 (residue 51–58)3a4 (63–74)3b2 (79–83)3b3 (90–96)
3 a5 (97–113). a2, b1, a3, a4, b2, and b3 are defined as a ‘‘winged helix motif.’’ The worm is colored according to the B factor of the side chain: red (low B, 25),
white (middle B, 45), and blue (high B, 80).
Table 1. Summary of crystallographic analysis









% Solutions¶ CO¶ R¶
Native I 2.8 4.3 62,396y20,967 78.0 2 47.2 46.6
Native II 2.3 2.7 77,545y37,403 96.5
Refinement (Native II)
Resolution, Å 20–4.58 3.65 3.19 2.90 2.69 2.53 2.40 2.30 Total
No. reflections 5696 5656 5512 5198 4788 4180 3454 2702 37,186
R-factor‡ 15.27 20.16 29.30 33.14 36.95 38.04 38.86 41.56 23.24
Free R-factor§ 21.94 24.45 32.45 38.65 39.36 38.79 35.91 38.02 28.22
rms deviations; Bonds, 0.009 Å; Angles, 1.4°
*Crystal spacegroup P1; a 5 64.7 Å, b 5 70.6 Å, c 5 75.5 Å, a 5 65.7°, b 5 67.2°, g 5 69.6°, two SarR-MBP monomersyunit cell.
†Rmerge 5 100 3 SjuIj 2 ^I&uySjIj with Bijvoet pairs treated as equivalent.
‡R-factor 5 SuFobs 2 FcalcuySFobs for all amplitudes with Fys(F) $ 2 measured in the indicated resolution bin.
§Free R-factor was calculated with 5% of the data in each bin.
¶Molecular replacement solutions, CO, (correlation coefficients); and R, are defined in AMORE (19).
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(Table 1). The final model contains residues 1–115 for molecule
1 of SarR, residues 1–115 for molecule 2 of SarR (Fig. 1B),
residues 1–372 for both MBP molecules (Fig. 1 A), two maltose
molecules, and 190 water molecules. Stereochemical values are
all within or better than the expected ranges for a 2.3-Å
structure, as determined by using PROCHECK (23).
Results and Discussion
Overall Structure. The structure of SarR-MBP fusion protein
shows that the SarR dimer is located at the top of the two
individual MBP molecules, connected by two loops (with resi-
dues both from SarR and modified MPB) between SarR and
MBP. The positions of the MBP molecules suggest that they did
not influence the structure of SarR dimer (Fig. 1 A). The overall
structure of the SarR monomer consists of five a helices, three
short b strands, and several loops (Fig. 1B). The a1 helix extends
out from the remaining molecule, forming an ‘‘L’’-like structure
with a stretch formed from the N-terminal residues of the
protein. The a2 helix follows a 7-residue loop from a1, and is
almost perpendicular to a1 (85°). The three b strands, b1, b2,
and b3, form an antiparallel bundle, which is slightly twisted. a5
follows immediately after b3. Between b1 and b2 is a long
flexible region (residues 51–79), which had poor electron density
in the initial 2Fo-Fc and Fo-Fc maps, containing two helices, a3
(residue 51–56) and a4 (residue 63–75), respectively, and a short
turn (residue 56–58); these three elements build up a typical
helix–turn–helix structural module existing in DNA binding
proteins. Homology alignment (DALI; ref. 24) of the SarR
structure with all available structures shows that the SarR
monomer is homologous to winged helix proteins (25), such as
transcription regulatory protein mota fragment (PDB ID code
1bja) with a Z score of 8.0 and transcriptional repressor smtb
activation domain (PDB ID code 1smt) with a Z score of 7.2.
Compared with winged helix proteins, the ‘‘W2’’ is replaced by
a helix (a5) and the ‘‘W1’’ extends much further in the SarR
monomer (Fig. 1B). Therefore, we postulate that SarR and its
family of proteins likely are new members of the classic winged
helix protein family.
Two L-like structures of a1 and the stretch of the N-termini
come together, forming a dimer that has an elongated, slightly
bent structure with overall dimensions of 71 Å 3 37 Å 3 34 Å
(Fig. 2 A, B, and C). The monomers are related to each other by
a noncrystallographic local 2-fold axis. On the concave side and
middle of the SarR dimer, there is a canyon-like structure with
a length of ’35 Å, a width of ’25 Å, and a depth of ’10 Å (Fig.
2 A and B). The canyon is formed by a part of a1, the loop that
connects a1 and a2 and a part of a2 as its bed, and with a4 from
both monomers acting as the two banks (Fig. 2 A and B). On the
convex side, all four termini (C- and N-termini of both mole-
cules) form a flat platform with the N terminus of one monomer
adjacent to the C terminus of the other (Fig. 2C). This feature
may possibly explain how SarS, a 250-residue protein homolo-
gous to SarA (26), may function as a heterodimer-like monomer
because it contains two sections, each highly similar to the SarR
module and 125 residues long (26). The entire dimer can be
described as three individual subdomain structures (Fig. 2 A).
Three b strands plus a3 and a4 from each molecule form
subdomains 1 and 2, respectively. Those two subdomains were
poorly defined in the initial electron density map, which also was
reflected by their high temperature factors compared with the
rest in the final model (Fig. 1B), and thus can be expected to have
high mobility in the molecule in solution. Subdomain 3, consist-
ing of the major a helices a1, a2, and a5 from both monomers,
is relatively rigid because of the restraints of hydrophobic
interactions. These helices in subdomain 3 are arranged in such
a manner that the entire subdomain looks like a twisted letter Z
with the relatively flexible subdomain 1 and subdomain 2
covering its ends. The Z-shaped scaffold, a unique structural
feature for SarA family, could also represent a new functional
protein fold (Fig. 2 A and C).
Dimerization Interfaces. Several lines of evidence suggest that,
with the exception of SarS, the active form of the SarA family of
proteins may be a homodimer. First, there is strong evidence
showing that SarA exists as a homodimer in vitro as well as in vivo
(15). Second, on mixing partially unfolded (4 M urea) full-length
SarR protein and SarR-MBP fusion, a heterodimer product
containing one copy each of SarR and SarR-MBP fusion could
be separated by gel-filtration chromatography (data not shown).
Third, we used crystals of SarR-MBP fusion protein to solve the
SarR structure (see Materials and Methods). The SarR exists as
dimer even in the MBP fusion form and we postulate that the
dimerization form may be the active form existing in vivo.
Fourth, based on the homodimer SarR structure, the interac-
tions between the two monomers are quite extensive, with most
residues involved in hydrophobic interactions (Figs. 1 A and 3).
Residues Leu-10, Ile-7, and Ile-4 from one monomer and
Fig. 2. Structure of the SarR dimer. One SarR monomer is colored green, the
other is yellow. (A) View of concave side along the dimer 2-fold axis of the SarR
dimer, subdomain 1 contains b1, a3, a4, b2, and b3 (labeled blue) from one
monomer, subdomain 2 contains b1, a3, a4, b2, and b3 (also labeled blue)
from the other, and subdomain 3 contains a1, a2, and a5 (labeled red) from
both monomers. (B) View perpendicular to the dimer 2-fold. (C) View of the
convex side of the SarR dimer; N1 and C1 are the N terminus and C terminus
of molecule 1; N2 and C2 are the termini of molecule 2.









residues Phe-20, Ile-35, Leu-109, and Ile-113 from the other
monomer form two hydrophobic cores. The dimer interface
buries ’1,500 Å2 of solvent-accessible surface area (1.4-Å probe;
ref. 28) per monomer. Considering this hydrophobic feature of
SarR dimerization, we believe that the dimer of SarR in the
fusion protein is also the functional dimer in vivo. Furthermore,
the L-like structure of a1 and the stretch of the N terminus of
SarR physically block the dissociation of one monomer from its
partner. This blockage explains why an extremely harsh condi-
tion (4 M urea) is required to disrupt the dimerization of
individual monomers. Fifth, deletion analysis showed that mu-
tated SarA, with a 15-residue truncation at its N terminus, exists
as monomers in vitro (in solution or crystal packing forms; data
not shown). Finally, as predicted from the sequence alignment of
SarA, SarR, and SarS, most residues that are involved in the
dimerization process are highly conserved (Fig. 3).
DNA Binding and Bending. As reported earlier, SarA and SarR
proteins contain a high percentage of the residue Lys (29).
Remarkably, most of the Lys residues are highly conserved
between these two proteins (Fig. 3). It was predicted that most
of these Lys residues are involved in DNA binding (29). Al-
though the Lys residues are distributed throughout the entire
primary sequence, in the 3D structure most Lys residues and
some Arg residues are located primarily on one surface of the
SarR dimer (the concave side). The electrostatic potential on
this surface of the SarR dimer, calculated by the GRASP program
(28), revealed a positively charged track on this side (Fig. 4A).
Additionally, the two winged helix motifs (subdomain 1 plus a2
from one monomer and subdomain 2 plus a2 from another
monomer) are located on this side. We conclude that this side is
the most likely site for DNA binding.
Using the program DALI to search for proteins with a structure
similar to SarR, we examined manually every structure with a Z
score higher than 4. We found that the spatial arrangement of the
two SarR helix–turn–helix modules is quite similar to those
described for catabolite activator protein (CAP; ref. 30; PDB ID
code 1cgp with Z score of 4.7). Superposing the SarR winged
helix motifs 1 and 2 with the corresponding domains from CAP
dimer, the root mean square deviation (rmsd) of the a-carbon
backbone is 1.8 Å for motif 1, and 2.1 Å for motif 2 (Fig. 5A).
Interestingly, some of the residues involved in DNA binding and
bending in the CAP dimer, which interacts with the major
grooves, are conserved in the SarR dimer and in other members
of the SarA family (Fig. 3). For example, SarR-charged residues
that are predicted to interact with phosphate groups on the DNA
backbone are possibly Lys-52, Lys-56, Lys-71, and Arg-82. Lys-52
and Arg-82 are absolutely conserved in the SarR and SarA family
of proteins. Charged residues predicted to contact DNA bases
are Lys-61 and Lys-67. Lys-61 is also absolutely conserved.
Therefore, we predict that the SarR dimer and other SarA family
members have protein–DNA interaction similar to the CAP
dimer.
The interaction could cause the DNA to bend at two points by
’90° (30). The longest direct distance for the CAP and SarR
dimer surface is ’71Å (Fig. 4), which can hold a stretch of bent
Fig. 3. A sequence alignment of SarA homologs from S. aureus. The sequences are presented in one-letter amino acid code. Numbers at the beginning of each
line indicate amino acid positions relative to the start of each protein sequence. Helices are indicated by rectangles, b-sheets are indicated by arrows, and loops
are indicated by a line. ‘‘H’’ marked in green represents a residue that takes part in dimerization. ‘‘A’’ marked in red represents a residue that may compose of
the activation motifs. ‘‘D’’ marked in blue represents a residue that may be involved in the interaction of SarR with DNA. The sequence of DNA binding motif
from CAP is also aligned to the SarA proteins. A dot represents a residue(s) omitted and a dash represents a residue(s) missed in CAP. SarS2 starts at 1 (actual
position on SarS is 126).
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DNA with ’27 base pair nucleotides that has a length of ’92 Å
for a normal B form (30). This result is consistent with the
experimental DNA footprinting data, showing that ’29 nucle-
otides from the sarA promoter region were involved in binding
to SarR (31). This predicted bending of the DNA when SarR
binds to DNA may reflect a regulatory mechanism for the SarA
family of proteins in controlling target gene transcription.
We superimposed the SarR dimer on the CAP–DNA complex
to construct a model for a SarR–DNA complex (Fig. 5 B and C).
From this model, we can predict that, in addition to interactions
of the a4 helix with the DNA major groove, SarR may make
contacts with the DNA minor groove. The loop region between
b2 and b3 and part of the two b strands (W1, a b-hairpin) are
predicted to be quite flexible in the free SarR structure. Only
slight adjustments of their conformations are required to posi-
tion them to interact intensively with the minor groove of the
DNA. Several residues that could be involved in the interactions
are highly conserved residues (Asp-86, Glu-87, and Arg-88), with
perhaps the side chain of Arg-88 interacting with the DNA
phosphate backbone and the side chains of Asp-86 and Glu-87
interacting with bases (Fig. 5 B and C). There is no data so far
to show whether additional bending could be induced by this
interaction. This loop is too short in CAP and other winged helix
proteins to have this minor groove binding function (25). One
new member of one of the classes of winged helix proteins (RFX)
does make DNA minor groove contacts, but in this case, the wing
contacts the major groove and the helix contacts the minor
groove (32). Therefore, the predicted SarR type of wing-minor
groove interaction may be a unique feature of the SarA family
of proteins, thus establishing them as a third class of the winged
helix family (25, 32). The structure of DNA complexed with a
member of SarA family is needed to test this prediction.
The two subdomains that are involved in DNA binding and
bending in CAP have different conformations in the absence of
DNA, but are identical in the complex structure (25). The
corresponding subdomains (1 and 2) in SarR are almost identical
in the free protein, but most of the side chains are poorly defined.
We believe that these two subdomains have high mobility in the
absence of DNA, as has been described for the CAP protein. The
mobility can be indicated by their high temperature factors
(Fig. 1B).
Possible Regulation Mechanism. One class of transcription-
activating proteins bears two structural motifs, namely DNA
binding and activation domains (33). The SarR protein was
initially defined as a transcriptional repressor protein that binds
Fig. 4. The electrostatic potential surface of the SarR dimer calculated by
GRASP (28), with charge 11 for Lys and Arg, charge 21 for Glu and Asp, and
charge zero for all other residues. The color bar from red to blue represents
potential from negative to positive defined as in GRASP. The blue represents
positive charged potential and red represents negative charged potential. (A)
The potential surface of the concave side of SarR dimer (similar orientation as
Fig. 2A), the direct line distance of AB is ’65 Å. (B) The potential surface of the
convex side of the SarR dimer (similar orientation as Fig. 2C), two aspartic acid
residues are from one molecule, three glutamic acid residues from the other.
Fig. 5. (A) Superposition of two ‘‘winged helix motifs’’ (subdomain 1 plus a2
from one monomer and subdomain 2 plus a2 from another monomer) of SarR
dimer with the DNA binding domains of CAP (PDB ID code 1cgp), subdomains
from SarR marked green and yellow respectively, subdomains from CAP
marked blue and red. a4 and W1 interact with DNA at major grooves and
minor grooves, respectively. (B) The DNA binding model of SarR and DNA
(similar orientation as in Figs. 2A and 5A). The SarR dimer is superposed to that
of CAP. The DNA structure is from the CAP–DNA complex structure (PDB ID
code 1cgp). The wing region (W1) conformation is slightly adjusted to fit in the
minor groove. (C) A 90° orientation from the view of Fig. 5B.









the sarA promoter region (29), thus leading to reduced tran-
scription from the sar P1 promoter. Because the sarA P1
promoter is the predominant promoter in the sarA regulatory
system, we predicted and recently confirmed that the expression
of SarA was increased in a sarR mutant (29). Transcriptional
fusion studies also indicated that the sarA locus may be auto-
regulatory (31), possibly mediated by the binding of SarA to its
own promoter. It was postulated that an activation motif might
be present on the SarA protein but not on the SarR protein, and
that SarR may repress by a simple competitive displacement
mechanism. Indeed, we have found that the binding affinity of
SarR to a sarA promoter fragment is higher than its SarA
counterpart (16). A second possibility is that SarA and SarR may
form a heterodimer to interfere with the function of the SarA
homodimer. Because of the conservation of residues involved in
the dimerization, this could happen in vivo, although we have so
far failed to generate a heterodimer of SarA and SarR when
using His-tag proteins in vitro. Nevertheless, attempts to yield
heterodimers with native SarA and SarR proteins without any
His-tags are in progress. Finally, SarR may function in a manner
similar to the bacteriophage lambda repressor (which also has a
helix–turn–helix DNA binding motif). In this case, a slight
difference in DNA binding site (one base pair shift) could turn
an activator into a repressor by affecting RNA polymerase
binding (34).
The structure of the SarR protein, combined with the se-
quence alignment of additional SarA family members (Fig. 3),
suggests that the regulatory mechanism may be much more
complicated. Although there is no isolated activation domain in
the SarR dimeric structure compared with the CAP, a calcula-
tion of the surface electronic potential revealed two negatively
charged patches on the convex side of the SarR dimer (Fig. 4B).
These patches include residues Asp-6 and Asp-9 from molecule
1 and Glu-108, Glu-110, and Glu-111 from molecule 2. Many
transcription regulators work by binding DNA and then inter-
acting with a component of the RNA polymerase machinery
(33). For example, CAP regulates downstream protein expres-
sion mostly through its interactions with the C-terminal domains
of the a subunit of RNA polymerase (35). It is tempting to
speculate that these acidic patches on the surface of SarR may
represent activation motifs that allow SarR to regulate gene
expression in a similar way as SarA. Because Glu-108, Glu-110,
and Glu-111 are not conserved among the SarA family (Fig. 3),
this activity may have different specificities among the family
members. In this regard, we have experimental evidence to
suggest that SarR, besides interacting with the sarA promoter
acting as a repressor, also directly binds to the hla promoter (e.g.,
a hemolysin gene) as an activator, thus bypassing the effect of
SarA in controlling target gene expression (data not shown).
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